$5.50
+0.30 (+5.77%)
Analyst Consensus
Strong Buy
9
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+47.6% upside
Low Target
$6.66
Average Target
$8.12
High Target
$12.47
Current Price
$5.50
Current
$5.50
$5.50
Target
$8.12
$8.12
$6.66
$8.12 avg
$12.47
Scenario Analysis
Bear Case
$6.66
21.1%
Low target
Base Case
$8.12
+47.6%
Avg target
Bull Case
$12.47
+126.7%
High target
Risk/Reward
6.0x
Highly favorable
Price in Context
52-Week High
$10.48
-47.5% from high
52-Week Low
$3.53
+55.8% from low
Target vs 52W High
$8.12
-22.5% vs high
Next Earnings Report
Aug 17, 2026
8d
until earnings
EPS Est: $-0.52
Earnings in 8 days. Analyst targets may shift significantly after the report.
Peer Consensus — Pharmaceuticals